News from keryx biopharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 22, 2014, 07:30 ET

Keryx Biopharmaceuticals Announces Commercial Launch of AURYXIA™ (ferric citrate) Tablets in the United States

 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") today announced it has begun shipping AURYXIA™ (ferric citrate) tablets to...

Jan 22, 2014, 19:42 ET

Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced the pricing of an underwritten public offering of common stock consisting of...

Jan 21, 2014, 16:19 ET

Keryx Biopharmaceuticals, Inc. Announces $90 Million Proposed Public Offering of Common Stock

 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that it has commenced a $90 million underwritten public offering of shares of...

Jan 17, 2014, 08:00 ET

Keryx Biopharmaceuticals Announces Marketing Approval of Ferric Citrate in Japan

 Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that its Japanese partner, Japan Tobacco Inc. (JT), has received manufacturing...

Aug 08, 2013, 08:30 ET

Keryx Biopharmaceuticals Announces New Drug Application Submission for Zerenex™ for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis

Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug...

Jun 03, 2013, 08:30 ET

Keryx Biopharmaceuticals, Inc. Announces Zerenex™ Phase 3 Data Presented at the 2013 World Congress of Nephrology

 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced the presentation of updated efficacy and safety data from the Phase 3 long-term...

May 07, 2013, 16:30 ET

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

May 06, 2013, 16:30 ET

Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

Mar 14, 2013, 08:56 ET

Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the...

Mar 13, 2013, 08:30 ET

Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

Mar 11, 2013, 16:30 ET

Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

Mar 11, 2013, 08:30 ET

Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

Feb 22, 2013, 08:30 ET

Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the...

Feb 08, 2013, 08:30 ET

Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the...

Jan 30, 2013, 22:11 ET

Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced the pricing of its previously announced underwritten public offering of common...

Jan 29, 2013, 16:26 ET

Keryx Biopharmaceuticals Announces $55 Million Proposed Public Offering of Common Stock

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced that it has commenced a $55 million underwritten public offering of shares of its...

Jan 28, 2013, 07:00 ET
Jan 27, 2013, 18:15 ET

Keryx Biopharmaceuticals to Hold Conference Call Tomorrow at 8:00 AM ET to Discuss Top-Line Results from Zerenex™ Phase 3 Long-Term Study

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) will host a conference call tomorrow, Monday, January 28, at 8:00am ET to review the top-line...

Jan 07, 2013, 16:30 ET

Keryx Biopharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the...

Jan 07, 2013, 08:00 ET

Keryx Biopharmaceuticals Announces Filing of New Drug Application for Marketing Approval of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco Inc.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that its Japanese partner, Japan Tobacco Inc. (JT), has filed its New Drug Application...